Scholarly article on N-Benzyloxycarbonyl-threo-N,β-dimethyl-L-leucin 20544-89-2 from Journal of the American Chemical Society p. 875 - 879

DOI: 10.1021/ja00784a041

Source and publish data:

Journal of the American Chemical Society p. 875 - 879 (1973)

Update date:2022-08-04

Topics:

Authors:

Sheehan,J.C.

Ledis,S.L.

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1021/ja00784a041

Full text of DOI:10.1021/ja00784a041

Products guided by the article

Product name:N-Benzyloxycarbonyl-threo-N,β-dimethyl-L-leucin

Cas No:20544-89-2

R&D Labs maybe for 20544-89-2

Shanghai Egoal Chemical Co.,Ltd

Contact:+86-21-50333091

Address:Yangming Garden Square 3,YangGao North Road 1188, Pudong New District, Shanghai
Hangzhou utanpharma Co., Ltd

Contact:86-571-87758773

Address:Room604 ,6F, Block A1-3 Xixi Plaza,No. 588 Wenyi West RD, Hangzhou,310012, China
Landz International Company Ltd.

Contact:0086-21-58891610

Address:985 Dongfang Road, Pudong, Shanghai 200122 China
SuZhou LaiTeou

Contact:+86-0512-88957371

Address:shanghai
Zibo Linzi Darong Fine Chemical Co., Ltd(expird)

Contact:86-532-67773200; 15689126900

Address:Qidu town,Linzi district,Zibo city,Shandong province,China

Relevant to this article

Preparation of enol ethers by carbonyl olefination utilizing an alkoxymethyl chloride-titanocene(II) system

Doi:10.1016/j.tetlet.2003.09.013
(2003)
Doi:10.1039/j29680001036
(1968)
Discovery of a novel benzyloxyisoquinoline derivative with potent anti- Helicobacter pylori activity

Doi:10.1016/S0960-894X(98)00335-7
(1998)
Doi:10.1063/1.1747272
(1949)
Structure-activity relationships of a series of 1-substituted-4-methylbenzimidazole neuropeptide Y-1 receptor antagonists

Doi:10.1016/S0960-894X(98)00048-1
(1998)
Design of plasma kallikrein inhibitors: Functional and structural requirements of plasma kallikrein inhibitors

Doi:10.1248/cpb.46.452
(1998)

Article Doi

DOI: 10.1021/ja00784a041